Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-21-000002
Filing Date
2021-01-04
Accepted
2021-01-04 12:35:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 sunesis13g.htm SC 13G 28804
  Complete submission text file 0000935836-21-000002.txt   30171
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 21500899
SIC: 2834 Pharmaceutical Preparations

Mailing Address 467 CPW NY NY 10025
Business Address
LYTTON LAURENCE W (Filed by) CIK: 0001105806 (see all company filings)

Type: SC 13G